An assessment of prognostic immunity markers in breast cancer

Tumor-infiltrating lymphocytes (TIL) and immunity gene signatures have been reported to be significantly prognostic in breast cancer but have not yet been applied for calculation of risk of recurrence in clinical assays. A compact set of 17 immunity genes was derived herein from an Affymetrix-derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Benlong, Chou, Jeff, Tao, Yaozhong, Wu, Dengbin, Wu, Xinhong, Li, Xueqing, Li, Yan, Chu, Yiwei, Tang, Feng, Shi, Yanxia, Ma, Linlin, Zhou, Tong, Kaufmann, William, Carey, Lisa A, Wu, Jiong, Hu, Zhiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206135/
https://www.ncbi.nlm.nih.gov/pubmed/30393759
http://dx.doi.org/10.1038/s41523-018-0088-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206135/
https://www.ncbi.nlm.nih.gov/pubmed/30393759
http://dx.doi.org/10.1038/s41523-018-0088-0

Ejemplares similares